Last week’s annual meeting of the Massachusetts Biotechnology Council closed with an on-stage interview — billed as a “fireside chat” — with Tony Coles, a nationally-known figure in the drug industry.
Coles is now CEO of the company he founded and largely funded along with co-founder Susan Lindquist, Cambridge-based Yumanity Therapeutics.